VAR2 Pharmaceuticals is a biotechnology company developing first-in-class therapeutics targeting oncofetal Chondroitin Sulfate, a group of pan-cancer, tumor-specific glycosaminoglycans discovered by us in 2012 and holding promise of treating many different types of cancer.
| Website | https://var2pharmaceuticals.com/ |
| Employees | 9 (4 on RocketReach) |
| Founded | 2012 |
| Phone | +45 78 70 19 00 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Cancer Treatment, First-In-Class, Cancer Research, Therapeutics, Targeted Therapy, Drug Development, Biopharmaceutical, Drug Discovery, Innovative Therapies, Pharmaceutical Research, Precision Medicine, Biotechnology Advancements, Clinical Trials, Pharmaceutical Innovation |
| Competitors | Amgen, Genentech, Bristol Myers Squibb, Gilead Sciences, Regeneron, Receptos, a wholly-owned subsidiary of Celgene, Lilly India, Pfizer, Johnson & Johnson, AstraZeneca +43 more (view full list) |
Looking for a particular VAR2 Pharmaceuticals employee's phone or email?
VAR2 Pharmaceuticals Questions
Tobias Gustavsson is the Director CMC development of VAR2 Pharmaceuticals.
4 people are employed at VAR2 Pharmaceuticals.
Top VAR2 Pharmaceuticals Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
